You have no items in your shopping cart.
Revolax is a brand name for a group of hyaluronic acid dermal fillers made by Across Co., Ltd., which is based in South Korea. There is Revolax Sub-Q, Revolax Deep, and Revolax Fine. Revolax fillers only use high purity hyaluronic acid that is nonanimal-based and is completely natural so as to increase synchronization with human tissues when injected. These fillers also utilize a unique cross-linking technology that enables them to be more highly viscous. The resulting consistency of these fillers allows them to impart immediate and long-lasting volume augmentation and also allows the products to degrade uniformly within the skin. Furthermore, the unique formulations of these fillers gives them a highly consistent monophasic structure that benefits patients by being more stable and consistent, which in turn allows for smoother injections and stronger support within skin structures. Lastly, these fillers have a low phase angle percentage that reduces the risk of these products migrating away from their treatment sites.
Revolax fillers are each formulated to treat different dermal issues. More specifically, Revolax Fine targets superficial dermal lines, such as glabellar lines, neck wrinkles, and crow’s feet. Revolax Sub-Q can augment the cheeks, nose, and chin and can rectify deep or severe wrinkles and nasolabial folds. Meanwhile, Revolax Deep targets deep wrinkles and nasolabial folds; it can also be used for augmenting the lips, cheeks, and chin.
Revolax is manufactured by Across Co., Ltd., which is based in South Korea.
The most common side effects of Revolax fillers are injection site-related reactions, such as pain, redness, swelling, and bruising that occurs right after treatment. These generally do not require any medical intervention. More serious complications include nodule formation and the Tyndall effect. Nodular formation is typically due to the body recognizing the injected hyaluronic acid as a foreign material and forming a protective barrier around it in response. The Tyndall effect is due to superficial placement of the hyaluronic acid dermal filler. These side effects can be resolved with the injection of hyaluronidase, an enzyme capable of dissolving hyaluronic acid. The most serious potential issue with these fillers is inadvertent injection into the blood vessels that leads to vascular compromise. Though this is exceedingly rare and is thought to mainly be due to poor technical skills on the part of the injector, patients should still be informed of this, as it can cause permanent scars, blindness, and even a stroke.
Revolax Fine, Revolax Sub-Q, and Revolax Deep are each well-suited for different groups of patients. In other words, each of these fillers should only be used on patients with the appropriate condition(s). For instance, patients with superficial lines are ideal candidates for injection(s) of Revolax Fine, those with severe wrinkles are ideal candidates for treatment with Revolax Sub-Q, and those with deep wrinkles are ideal for treatment with Revolax Deep.
Revolax fillers do not contain any steroids, anti-inflammatory drugs, antibiotics, and any fragrances.
The main difference between these fillers is that they are each designed to treat different conditions and, by extension, different areas. For example, Revolax Fine can treat finer or more superficial lines and contour the lips, and it should be injected into the superficial dermis. Meanwhile, Revolax Deep can treat deep nasolabial folds and should be injected into the mid-to-deep dermis layer or even the subcutaneous layer in some cases. Lastly, Revolax SubQ can ameliorate severely deep lines and augment the jawline, and it should be injected deep into the subcutaneous layer.
It is imperative that patients who are pregnant or breastfeeding, under the age of 18, have a known history of allergic reactions to hyaluronic acid or lidocaine, have a known history of developing hypertrophic scarring, or have signs of skin infection are not treated with a Revolax filler.
If the patient has any history of labial or facial herpes simplex or varicella zoster, prescribe prophylactic antiviral medications. It is recommended that treatment with a Revolax filler is scheduled well in advance of any social events. Pretreatment photographs of the patient at rest and with muscles contracting at the treatment area are advisable. Treatment with a Revolax filler should not be done immediately before or after other skin rejuvenating procedures such as laser therapy, chemical peeling, and dermabrasion.
When injecting into the superficial dermis (as for Revolax Fine), significant resistance is felt, and the needle tip should still be visible.
When injecting into the dermis (as for Revolax Deep), slight resistance is felt as the needle is advanced. There should also be slight plunger resistance during injection, and the needle tip should not be visible.
When injecting into the subcutaneous tissues (as for Revolax Sub-Q), no resistance is felt, and the needle tip should not be visible.
When injecting any of these fillers, ensure a firm constant pressure against the plunger. Release the plunger before pulling the needle out of the skin to avoid tracking the dermal filler into the epidermis. Two main methods for injecting hyaluronic acid dermal fillers are available: fanning and cross-hatching. Fanning is usually used for the nasolabial folds and is where a single needle insertion point is determined and followed by a series of adjacent linear threads. Cross-hatching is when multiple insertion points are used with placement of linear threads in a grid pattern.
Every 1.1ml syringe for Revolax Sub-Q, Revolax Deep, and Revolax Fine each contain 24mg/ml of cohesive polydensified hyaluronic acid dermal filler that is mixed with 0.3% lidocaine. The complex viscosity for Revolax Fine, Revolax Deep, and Revolax Sub-Q is 80, 160, and 280, respectively.
A pack of Revolax Fine comes with two single-use and sterile 30G needles and one prefilled syringe that contains 1.1ml of the filler. A box of Revolax Sub-Q comes with two single-use 25G needles and one prefilled syringe that contains 1.1ml of the filler. A pack of Revolax Deep comes with two disposable and sterile 27G needles and one prefilled syringe that contains 1.1ml of the filler. All packages of Revolax fillers come with a package insert.
Disclaimer: Raskel Medical offers only genuine products made by their original manufacturer. All brands are trademarks of their respective owners. Raskel Medical is not operated by, supported by, or affiliated with the manufacturer in any way. Product packaging may not be exactly as shown.